Welcome to our dedicated page for Almacenes Exito SA news (Ticker: EXTO), a resource for investors and traders seeking the latest updates and insights on Almacenes Exito SA stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Almacenes Exito SA's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Almacenes Exito SA's position in the market.
Almacenes Éxito (NYSE: EXTO) has announced its Board's approval to voluntarily delist its American depositary shares (ADSs) from the NYSE and deregister under the U.S. Securities Exchange Act. The company plans to file Form 25 with the SEC on December 30, 2024, with delisting expected to become effective ten days later. The last trading day on NYSE is expected to be around January 9, 2025.
The decision stems from the company's reduced free float of 13.2% (1.6% in Colombia, 1.6% in US, and 10% in Brazil) and aims to create a more efficient structure by concentrating trading in the Colombian market. The ADS program, managed by JPMorgan, will terminate on January 21st, 2025. The company's common shares will continue trading on the Colombian Stock Exchange (BVC), while alternatives for its Brazilian BDR program are under evaluation.